MediWound (MDWD) Accounts Payables (2013 - 2026)
MediWound (MDWD) posted quarterly Accounts Payables of $7.6 million for Q4 2025, up 44.82% year-over-year from $5.3 million in Q4 2024, and down 10.13% quarter-over-quarter from $8.5 million in Q3 2025.
MediWound (MDWD) Accounts Payables (2013 - 2026) Analysis & Trends
MediWound's Accounts Payables history runs 13 years deep, the most recent figure standing at $7.6 million for Q4 2025.
- In Q4 2025, Accounts Payables rose 44.82% year-over-year to $7.6 million; the TTM figure through Dec 2025 stood at $7.6 million (up 44.82% YoY), while the FY2025 annual figure was $7.6 million, up 44.82% from the prior year.
- Accounts Payables for Q4 2025 stood at $7.6 million, down from $8.5 million in the prior quarter.
- The five-year high for Accounts Payables was $8.5 million in Q3 2025, with the low at $2.7 million in Q2 2024.
- The 5-year median for Accounts Payables is $4.5 million (2021), against an average of $4.7 million.
- The sharpest annual moves came in 2023 and 2025: Accounts Payables tumbled 39.48% in 2023, then jumped 171.8% in 2025.
- MediWound's Accounts Payables stood at $4.7 million in 2021, then grew by 20.52% to $5.7 million in 2022, then declined by 2.26% to $5.5 million in 2023, then decreased by 4.47% to $5.3 million in 2024, then surged by 44.82% to $7.6 million in 2025.
- Business Quant data shows MDWD's Accounts Payables at $7.6 million in Q4 2025, $8.5 million in Q3 2025, and $5.9 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 429.50 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 1.16 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 1.52 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 167.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 470.30 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 108.02 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 622.65 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 428.93 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 35.57 Mn |
| 10 | MediWound | 170.65 Mn | 139.65 Mn | 337,000.00 | 7.63 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 7.63 Mn |
| Dec 31, 2025 | 7.65 Mn |
| Sep 30, 2025 | 8.51 Mn |
| Jun 30, 2025 | 5.88 Mn |
| Mar 31, 2025 | 4.99 Mn |
| Dec 31, 2024 | 5.28 Mn |
| Sep 30, 2024 | 3.13 Mn |
| Jun 30, 2024 | 2.75 Mn |
| Mar 31, 2024 | 4.25 Mn |
| Dec 31, 2023 | 5.53 Mn |
| Sep 30, 2023 | 3.68 Mn |
| Jun 30, 2023 | 3.53 Mn |
| Mar 31, 2023 | 3.40 Mn |
| Dec 31, 2022 | 5.66 Mn |
| Sep 30, 2022 | 3.57 Mn |
| Jun 30, 2022 | 4.88 Mn |
| Mar 31, 2022 | 5.62 Mn |
| Dec 31, 2021 | 4.69 Mn |
| Sep 30, 2021 | 3.71 Mn |
| Jun 30, 2021 | 4.06 Mn |